Company Filing History:
Years Active: 2013-2014
Title: Innovations by Manoj Kumar Khera: A Focus on Matrix Metalloproteinase Inhibitors
Introduction:
Manoj Kumar Khera is an innovative inventor based in Gurgaon, India, who has contributed significantly to the field of pharmaceuticals with a total of four patents to his name. His work primarily focuses on the development of matrix metalloproteinase inhibitors, showcasing his commitment to addressing various inflammatory and autoimmune diseases through scientific advancements.
Latest Patents:
Among his latest patents, Khera has developed compounds related to β-hydroxy and amino-substituted carboxylic acids, which are specifically identified as matrix metalloproteinase inhibitors. These diastereomerically pure β-hydroxy carboxylic acids play a crucial role in the synthesis of pharmaceutical compositions. The compounds are designed to treat a wide range of inflammatory, autoimmune, and allergic diseases, including but not limited to asthma, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and various types of cancer. These inventions demonstrate his dedication to improving treatment methods for conditions characterized by the over-expression and over-activation of matrix metalloproteinases.
Career Highlights:
Manoj Kumar Khera is associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His work in this capacity reflects his deep involvement in drug development and innovation. Khera's portfolio of patents highlights the impact of his inventions in the medical field and his ongoing contribution to advancing healthcare solutions.
Collaborations:
Throughout his career, Khera has collaborated with talented professionals, including Viswajanani Jitendra Sattigeri and Venkata Poornapragnacharyulu Palle. These collaborations have fostered an environment of creativity and knowledge exchange, further enhancing the innovative outcomes of their collective efforts in pharmaceutical research.
Conclusion:
Manoj Kumar Khera stands out as a notable inventor in the pharmaceutical domain, with a clear focus on developing solutions that address serious health issues. His patents related to matrix metalloproteinase inhibitors not only showcase his ingenuity but also hold the potential to significantly improve treatment protocols for various diseases. Khera's continued innovation is likely to have a lasting impact on healthcare, paving the way for further advancements in the industry.